New Second-Line Combo Therapy for MSS Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
- Status
- RECRUITING
- Phase
- PHASE3
A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI
- Status
- RECRUITING
- Phase
- PHASE1
JS212 Combination Therapies in Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)
- Status
- RECRUITING
- Phase
- PHASE1
Testing Ivonescimab in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancers Without Liver Metastases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Phase II Study of EMB-01 in Recurrent/Metastatic Colorectal Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Second- and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer.
- Status
- RECRUITING
- Phase
- N/A
A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
BETWEEN: Biweekly Bevacizumab + Trifluridine/Tipiracil to Reduce Grade 3-4 Neutropenia in mCRC Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Glumetinib Combined With Fruquintinib in the Treatment of MET Amplification or Protein Overexpression in Third-Line Unresectable Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Study on the Efficacy and Safety of Fruquintinib in Combination With PD-1 Monoclonal Antibody and Chidamide in Refractory MSS Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Testing a Functional Precision Medicine Approach to Select Chemotherapy for Metastatic Colorectal Cancer (COSENSE-1)
- Status
- RECRUITING
- Phase
- PHASE2
Trial of ProAgio in Advanced/Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Chidamide in Combination With PD-1 Inhibitor, Bevacizumab, and XELOX for Metastatic Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2